HCAT
Health Catalyst·NASDAQ
--
--(--)
--
--(--)
4.41 / 10
Netural
Analyst coverage is limited and neutral, with one opinion from Citigroup rating it 'Neutral'. Fund flow metrics show a good overall score of 7.61/10, indicating positive capital movement, though medium and large flows are negative. This divergence between strong block and extra-large inflows versus weaker medium/large inflows hints at institutional accumulation but retail hesitation.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-09
InstitutionCitigroup
Times predicted4
Historical Win Rate25.0%
What is the analyst consensus for HCAT?
- HCAT holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.41/10 (Netural).
